Jenny Hallgren

Jenny Hallgren

Auto-generated profile, based on publicly available information

Jenny Hallgren

Department of Medical Biochemistry and Microbiology Uppsala University Uppsala Sweden

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Molecular Immunology
Verified
Journal Article
Open access
JDJoakim S. Dahlin
Joakim S. Dahlin
JHJenny Hallgren
Jenny Hallgren
Mast cells in tissues are developed from mast cell progenitors emerging from the bone marrow in a process highly regulated by transcription factors. Through the advancement of the multicolor flow cytometry technique, the mast cell progenitor population in the mouse has been characterized in terms of surface markers. However, only cell populations with enriched mast cell capability have been described in human. In naïve mice, the peripheral tissues have a constitutive pool of mast cell progenitors. Upon infections in the gut and in allergic inflammation in the lung, the local mast cell progenitor numbers increase tremendously. This review focuses on the origin and development of mast cell progenitors. Furthermore, the evidences for cells and molecules that govern the migration of these cells in mice in vivo are described.

29 May 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
EMErika Méndez-Enríquez
Erika Méndez-Enríquez
JHJenny Hallgren
Jenny Hallgren
Mast cells and their mediators have been implicated in the pathogenesis of asthma and allergy for decades. Allergic asthma is a complex chronic lung disease in which several different immune cells, genetic factors and environmental exposures influence the pathology. Mast cells are key players in the asthmatic response through secretion of a multitude of mediators with pro-inflammatory and airway-constrictive effects. Well-known mast cell mediators, such as histamine and bioactive lipids are responsible for many of the physiological effects observed in the acute phase of allergic reactions. The accumulation of mast cells at particular sites of the allergic lung is likely relevant to the asthma phenotype, severity and progression. Mast cells located in different compartments in the lung and airways have different characteristics and express different mediators. According to in vivo experiments in mice, lung mast cells develop from mast cell progenitors induced by inflammatory stimuli to migrate to the airways. Human mast cell progenitors have been identified in the blood circulation. A high frequency of circulating human mast cell progenitors may reflect ongoing pathological changes in the allergic lung. In allergic asthma, mast cells become activated mainly via IgE-mediated crosslinking of the high affinity receptor for IgE (FcεRI) with allergens. However, mast cells can also be activated by numerous other stimuli e.g. toll-like receptors and MAS-related G protein-coupled receptor X2. In this review, we summarize research with implications on the role and development of mast cells and their progenitors in allergic asthma and cover selected activation pathways and mast cell mediators that have been implicated in the pathogenesis. The review places an emphasis on describing mechanisms identified using in vivo mouse models and data obtained by analysis of clinical samples.

28 January 2016 in Blood
Verified
Journal Article
Closed access
PDF file
JDJoakim S. Dahlin
Joakim S. Dahlin
AMAndrei Malinovschi
Andrei Malinovschi
HÖHelena Öhrvik
Helena Öhrvik
MSMartin Sandelin
Martin Sandelin
CJChrister Janson
Christer Janson
JHJenny Hallgren
Jenny Hallgren
Mast cells are rare tissue-resident immune cells that are involved in allergic reactions, and their numbers are increased in the lungs of asthmatics. Murine lung mast cells arise from committed bone marrow–derived progenitors that enter the blood circulation, migrate through the pulmonary endothelium, and mature in the tissue. In humans, mast cells can be cultured from multipotent CD34+ progenitor cells. However, a population of distinct precursor cells that give rise to mast cells has remained undiscovered. To our knowledge, this is the first report of human lineage-negative (Lin−) CD34hi CD117int/hi FcεRI+ progenitor cells, which represented only 0.0053% of the isolated blood cells in healthy individuals. These cells expressed integrin β7 and developed a mast cell–like phenotype, although with a slow cell division capacity in vitro. Isolated Lin− CD34hi CD117int/hi FcεRI+ blood cells had an immature mast cell–like appearance and expressed high levels of many mast cell–related genes as compared with human blood basophils in whole-transcriptome microarray analyses. Furthermore, serglycin, tryptase, and carboxypeptidase A messenger RNA transcripts were detected by quantitative reverse transcription–polymerase chain reaction. Altogether, we propose that the Lin− CD34hi CD117int/hi FcεRI+ blood cells are closely related to human tissue mast cells and likely constitute an immediate precursor population, which can give rise to predominantly mast cells. Furthermore, asthmatics with reduced lung function had a higher frequency of Lin− CD34hi CD117int/hi FcεRI+ blood mast cell progenitors than asthmatics with normal lung function. Publisher9s Note: There is an Inside Blood Commentary on this article in this issue. Key Points Human Lin− CD34hi CD117int/hi FcεRI+ cells in blood constitute mast cell progenitors. Asthmatics with reduced lung function have an increased frequency of circulating mast cell progenitors.


22 September 2000 in Biochemistry
Verified
Journal Article
Closed access
JHJenny Hallgren
Jenny Hallgren
UKUlrika Karlson
Ulrika Karlson
MPMaryam Poorafshar
Maryam Poorafshar
LHLars Hellman
Lars Hellman
GPGunnar Pejler
Gunnar Pejler

22 May 2001 in Biochemistry
Verified
Journal Article
Closed access
JHJenny Hallgren
Jenny Hallgren
SESergio Estrada
Sergio Estrada
UKUlrika Karlson
Ulrika Karlson
KAKjell Alving
Kjell Alving
GPGunnar Pejler
Gunnar Pejler